Bevacizumab (Avastin)

Supplement

An antibody drug developed by Genentech that targets VEGF, approved for colon cancer, but faced economic scrutiny due to its high cost and modest survival benefit.

Mentioned in 1 video

Videos Mentioning Bevacizumab (Avastin)

346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine

346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine

Peter Attia MD

An antibody drug developed by Genentech that targets VEGF, approved for colon cancer, but faced economic scrutiny due to its high cost and modest survival benefit.